India · English
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore
The deal includes trademarks registered in India and related intellectual property rights, with Minipress XL generating ₹228.6 crore revenue in the year ended July 2026.
Read the full report at The Hindu BusinessLine →
How 2 newsrooms ran it
2 of our sources carried this story over 0.6 hours. The Hindu BusinessLine filed first, at 13:15 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 13:15 | The Hindu BusinessLine | Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore |
| 13:54 | Business Standard | Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.